Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Physical Activity Steadily Declines From Young Adulthood to Middle Age
MVPA begins declining about 12 years before cardiovascular disease, with accelerated declines within two years of event
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
AOMs linked to significant weight regain at eight weeks after drug discontinuation compared with control group
A-Fib Linked to Worse Outcomes for Patients With Heart Failure, MR Undergoing Valve Repair
Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER
Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes
Patients hospitalized with RSV have greater risk for subsequent heart failure events compared with patients with influenza, UTI, fracture
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
23.8 and 50.4 percent of those with one and two or more moderate risk factors were recommended aspirin prophylaxis
Myocardial Fibrosis Linked to Ventricular Arrhythmia in Male Endurance Athletes
Myocardial fibrosis remained predictive after adjusting for left ventricular end-diastolic volume indexed
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
Prevalence of Extremely Severe Obesity Increasing in Children
2008 to 2023 saw relative increase of 253.1 percent for extremely severe obesity, which is linked to higher odds of metabolic complications
Similar Reduction Seen in Mortality for Exercise Patterns in Diabetes
Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality
